RocketVax

Description: RocketVax develops next-gen DNA-based vaccines, starting with RVX-13 for SARS-CoV-2, leveraging Swiss scientific expertise and proprietary tech.

Country: Switzerland

Based in: Basel

Founded: 2020

Funding Stage: Seed

Tags: ['Biotechnology', 'Chemical', 'Health Care', 'Life Science', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.